459 related articles for article (PubMed ID: 33412828)
1. [Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates].
Mantellini P; Battisti F; Armaroli P; Giubilato P; Ventura L; Zorzi M; Battagello J; Sassoli de Bianchi P; Senore C; Zappa M
Epidemiol Prev; 2020; 44(5-6 Suppl 2):344-352. PubMed ID: 33412828
[TBL] [Abstract][Full Text] [Related]
2. Le disuguaglianze di accesso ai programmi di screening dei tumori della mammella, del colon retto e della cervice uterina sono aumentate durante il periodo pandemico. Risultati di un health equity audit condotto dall'Agenzia di Tutela della Salute d.
Girardi D; Vecchio R; Tanious M; Cacitti S; Ancarani C; Dalle Carbonare S; Perotti P; Bonafede C; Cavallo R; Gentile L; Parrini A; Lucente EM; Carlesso A; Cadum E; Cecconami L; Odone A; Deandrea S
Epidemiol Prev; 2024; 48(2):130-139. PubMed ID: 38770730
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of predictive factors for non-adherence to organized screening for colorectal and breast cancers in the pre-pandemic period (2018-2019) in Lombardy Region (Northern Italy)].
Russo AG; Murtas R; Ballotari P; Cavalieri d'Oro L; Gambino ML; Fanetti AC; Maifredi G; Manzoni F; Sampietro G; Leoni O; Celata C; Cereda D; Deandrea S;
Epidemiol Prev; 2024; 48(2):118-129. PubMed ID: 38770729
[TBL] [Abstract][Full Text] [Related]
4. Cancer screening uptake: association with individual characteristics, geographic distribution, and time trends in Italy.
Carrozzi G; Sampaolo L; Bolognesi L; Sardonini L; Bertozzi N; Giorgi Rossi P; Zappa M; Baldissera S; Campostrini S; Ferrante G; Masocco M; Minardi V; D'Argenzio A; Moghadam PF; Quarchioni E; Ramigni M; Trinito MO; Salmaso S;
Epidemiol Prev; 2015; 39(3 Suppl 1):9-18. PubMed ID: 26405772
[TBL] [Abstract][Full Text] [Related]
5. Cancer screening programmes in Italy during the COVID-19 pandemic: an update of a nationwide survey on activity volumes and delayed diagnoses.
Battisti F; Falini P; Gorini G; Sassoli de Bianchi P; Armaroli P; Giubilato P; Giorgi Rossi P; Zorzi M; Battagello J; Senore C; Zappa M; Mantellini P
Ann Ist Super Sanita; 2022; 58(1):16-24. PubMed ID: 35324470
[TBL] [Abstract][Full Text] [Related]
6. [Cervical and breast cancer screening among immigrant women resident in Italy].
Francovich L; Di Napoli A; Giorgi Rossi P; Gargiulo L; Giordani B; Petrelli A
Epidemiol Prev; 2017; 41(3-4 (Suppl 1)):18-25. PubMed ID: 28929723
[TBL] [Abstract][Full Text] [Related]
7. Modeling Strategies to Optimize Cancer Screening in USPSTF Guideline-Noncompliant Women.
Taksler GB; Peterse EFP; Willems I; Ten Haaf K; Jansen EEL; de Kok IMCM; van Ravesteyn NT; de Koning HJ; Lansdorp-Vogelaar I
JAMA Oncol; 2021 Jun; 7(6):885-894. PubMed ID: 33914025
[TBL] [Abstract][Full Text] [Related]
8. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
[TBL] [Abstract][Full Text] [Related]
9. The diffusion of screening programmes in Italy, year 2009.
Zappa M; Dardanoni G; Giorgi Rossi P; Grazzini G; Naldoni C; Paci E; Pirola ME; Pizzuti R; Segnan N; Zorzi M; Federici A
Epidemiol Prev; 2011; 35(5-6 Suppl 5):3-7. PubMed ID: 22166346
[TBL] [Abstract][Full Text] [Related]
10. Mammography screening in Italy: 2005 survey and 2006 preliminary data.
Giorgi D; Giordano L; Ventura L; Frigerio A; Paci E; Zappa M
Epidemiol Prev; 2008; 32(2 Suppl 1):7-22. PubMed ID: 18770992
[TBL] [Abstract][Full Text] [Related]
11. Scelte gestionali per sostenere e migliorare i programmi di screening oncologico.
Chiereghin A; Squillace L; Pizzi L; Sanna T; Bazzani C; Roti L; Mezzetti F
Epidemiol Prev; 2024; 48(2):158-164. PubMed ID: 38770733
[TBL] [Abstract][Full Text] [Related]
12. A population-based survey of self-reported delays in breast, cervical, colorectal and lung cancer screening.
Gunn CM; Berrian K; Weiss JE; Tosteson AAN; Hasson RM; Di Florio-Alexander R; Peacock JL; Rees JR
Prev Med; 2023 Oct; 175():107649. PubMed ID: 37517458
[TBL] [Abstract][Full Text] [Related]
13. Cancer Screening Disparities Before and After the COVID-19 Pandemic.
Lofters AK; Wu F; Frymire E; Kiran T; Vahabi M; Green ME; Glazier RH
JAMA Netw Open; 2023 Nov; 6(11):e2343796. PubMed ID: 37983033
[TBL] [Abstract][Full Text] [Related]
14. [The diffusion of screening programmes in Italy, year 2010].
Zappa M; Dardanoni G; Giorgi Rossi P; Grazzini G; Naldoni C; Paci E; Pirola ME; Pizzuti R; Segnan N; Zorzi M; Federici A
Epidemiol Prev; 2012; 36(6 Suppl 1):3-7. PubMed ID: 23293267
[TBL] [Abstract][Full Text] [Related]
15. Adherence to the three Italian screening in a sample of women (and men) in the Southern Italy.
Genovese C; Squeri R; Alessi V; Conti A; D'Amato S; Mazzitelli F; Costa G; Squeri A
Clin Ter; 2021; 171(1):e75-e79. PubMed ID: 33346333
[TBL] [Abstract][Full Text] [Related]
16. Invitation coverage and participation in Italian cervical, breast and colorectal cancer screening programmes.
Giorgi Rossi P; Carrozzi G; Federici A; Mancuso P; Sampaolo L; Zappa M
J Med Screen; 2018 Mar; 25(1):17-23. PubMed ID: 28614991
[TBL] [Abstract][Full Text] [Related]
17. [Family Care Centres for health protection and promotion of individuals and communities: a reflection at the time of the Coronavirus].
Lauria L; Lega I; Pizzi E; Donati S;
Epidemiol Prev; 2020; 44(5-6 Suppl 2):374-379. PubMed ID: 33412832
[TBL] [Abstract][Full Text] [Related]
18. Social disparities in access to breast and cervical cancer screening by women living in Spain.
Ricardo-Rodrigues I; Jiménez-García R; Hernández-Barrera V; Carrasco-Garrido P; Jiménez-Trujillo I; López de Andrés A
Public Health; 2015 Jul; 129(7):881-8. PubMed ID: 25818014
[TBL] [Abstract][Full Text] [Related]
19. How uro-oncology has been affected by COVID-19 emergency? Data from Piedmont/Valle d'Aosta Oncological Network, Italy.
Oderda M; Calleris G; Falcone M; Fasolis G; Muto G; Oderda G; Porpiglia F; Volpe A; Bertetto O; Gontero P
Urologia; 2021 Feb; 88(1):3-8. PubMed ID: 33632087
[TBL] [Abstract][Full Text] [Related]
20. The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands.
Dinmohamed AG; Cellamare M; Visser O; de Munck L; Elferink MAG; Westenend PJ; Wesseling J; Broeders MJM; Kuipers EJ; Merkx MAW; Nagtegaal ID; Siesling S
J Hematol Oncol; 2020 Nov; 13(1):147. PubMed ID: 33148289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
